Pvr Chemphar Profile
Key Indicators
- Authorised Capital ₹ 2.25 Cr
- Paid Up Capital ₹ 2.25 Cr
- Company Age 18 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 17.03%
- Profit Growth 23.17%
- Ebitda -230.00%
- Net Worth 2.50%
- Total Assets 2.86%
About Pvr Chemphar
Pvr Chemphar Private Limited (PCPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 July 2006 and has a history of 18 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.25 Cr and a paid-up capital of Rs 2.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
Penaka Rani and Sarath Penaka serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24100TG2006PTC050599
- Company No.
050599
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jul 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pvr Chemphar?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Penaka Rani  | Director | 02-Jan-2012 | Current |
| Sarath Penaka | Director | 11-Jul-2006 | Current |
Financial Performance of Pvr Chemphar.
Pvr Chemphar Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.03% increase. The company also saw a substantial improvement in profitability, with a 23.17% increase in profit. The company's net worth moved up by a moderate rise of 2.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pvr Chemphar?
Unlock access to Pvr Chemphar's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Raidurgam Developers LimitedPenaka Rani is a mutual person
- Aurobindo Pharma Ltd
Sarath Penaka is a mutual person
- Aurobindo Pharma Foundation
Sarath Penaka is a mutual person
Sarath Penaka Enterprises LlpPenaka Rani and Sarath Penaka are mutual person
- Prr Enterprises Llp
Penaka Rani is a mutual person
- Penaka Pharma (India) Private Limited
Penaka Rani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pvr Chemphar?
Unlock and access historical data on people associated with Pvr Chemphar, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pvr Chemphar, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pvr Chemphar's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
